The Healthscope Ltd (ASX: HSO) share price was slammed 4% today after it announced the appointment of Gordon Ballantyne, who will replace Robert Cooke as CEO of the private hospital operator in May 2017. The broader market traded mostly flat for the majority of the session.
Here’s a quick recap:
- S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) up 0.1% to 5872 points
- ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) up 0.1% to 5909 points
- AUD/USD at US 76.06 cents
- Iron Ore at US$80.39 a tonne, according to the Metal Bulletin
- Gold at US$1,247.36 an ounce
- Brent oil at US$53.38 a barrel
Sitting at $2.18, the HSO share price has now shed 4.8% since the beginning of 2017.
The Orion Health Group Ltd (ASX: OHE) share price was also slammed 11.7% after the group said its full-year revenues would be lower than last year, although it confirmed it was still on track to achieve profitability in the 2018 financial year.
And the Blackmores Limited (ASX: BKL) share price dropped 2.3% for the day as well.
Here are Monday’s top stories:
- Top stock picks for April
- The Big Short: Are these 3 beaten-up shares an opportunity?
- 5 Aussie health shares I’m watching in 2017
This company’s dividend is almost the stuff of legends. Since it started paying dividends in 2007, it has increased its payout to shareholders every single year, a run that includes 21 consecutive dividend increases.
Based on the last 12-months of dividends, its shares are currently offering a fully-franked 4.8% yield, which grosses up to almost 7% when those franking credits are included. And in stark contrast to the likes of Commonwealth Bank and Telstra, this company just increased its dividend by over 13%, and guided for 2017 profits to grow by 20%!
Discover the name of this “new breed” of blue chip along with 2 others in our new FREE report "The Motley Fool’s Top 3 Blue Chips Stocks For 2017."
Click here to receive your copy.
Motley Fool contributor Ryan Newman has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.